A composite biomarker for esophageal cancer risk from automated analysis of a non-endoscopic device

Adam G. Berman, Rebecca C. Fitzgerald, Florian Markowetz
doi: https://doi.org/10.1101/2021.08.20.21262366

Article usage

Article usage: August 2021 to December 2024

AbstractFullPdf
Aug 2021417528
Sep 20218624949
Oct 20214141942
Nov 20211201414
Dec 2021135710
Jan 2022842511
Feb 2022511411
Mar 202270126
Apr 2022551912
May 2022421012
Jun 20223574
Jul 202237145
Aug 202233131
Sep 20224596
Oct 2022441612
Nov 202219143
Dec 20221964
Jan 2023273311
Feb 20231587
Mar 202320224
Apr 202330128
May 20231146
Jun 20239122
Jul 2023664
Aug 202318156
Sep 202315116
Oct 202310152
Nov 202318169
Dec 20232292
Jan 20242156
Feb 20241486
Mar 202410155
Apr 202410213
May 202410162
Jun 2024993
Jul 20241096
Aug 20243276
Sep 202418137
Oct 2024720
Nov 20241657
Dec 2024101
Back to top
Posted August 25, 2021.
Download PDF
Data/Code
Email
A composite biomarker for esophageal cancer risk from automated analysis of a non-endoscopic device
Adam G. Berman, Rebecca C. Fitzgerald, Florian Markowetz
medRxiv 2021.08.20.21262366; doi: https://doi.org/10.1101/2021.08.20.21262366
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area